Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Percutaneous myocardial laser revascularization (PMR)].

B Lauer1, F Stahl, S Bratanow

  • 1Klinik für Innere Medizin/Kardiologie, Herzzentrum, Universität Leipzig. laub@server3.medizin.uni-leipzig.de

Herz
|November 15, 2000
PubMed
Summary

Percutaneous myocardial laser revascularization (PMR) offers a less invasive alternative to transmyocardial laser revascularization (TMR) for severe angina. PMR improves symptoms and exercise capacity in end-stage coronary artery disease patients, though perfusion mechanisms remain unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Layer Detector Cone-Beam CT Angiography for Stroke Assessment: First-in-Human Results (the Next Generation X-ray Imaging System Trial).

AJNR. American journal of neuroradiology·2023
Same author

[Perioperative management of coagulation in otorhinolaryngologic surgery].

HNO·2022
Same author

Surgery for chronic subdural hematoma in nonagenarians: A Scandinavian population-based multicenter study.

Acta neurologica Scandinavica·2017
Same author

[Percutaneous myocardial laserrevascularization (PMR), a new therapy for patients with refractory angina pectoris].

Zeitschrift fur Kardiologie·2016
Same author

Detection of human genome mutations associated with pregnancy complications using 3-D microarray based on macroporous polymer monoliths.

Talanta·2015
Same author

Lost signature: progress and failures in in vivo tracking of implanted stem cells.

Applied microbiology and biotechnology·2015

Area of Science:

  • Cardiovascular Medicine
  • Minimally Invasive Surgical Techniques
  • Interventional Cardiology

Context:

  • Severe angina pectoris due to coronary artery disease (CAD) often limits treatment options to percutaneous coronary angioplasty or coronary artery bypass surgery.
  • Transmyocardial laser revascularization (TMR) improves symptoms but requires thoracotomy, posing a significant surgical risk.
  • A novel catheter-based system, percutaneous myocardial laser revascularization (PMR), has been developed to create laser channels into the myocardium from the left ventricular cavity, avoiding thoracotomy.

Purpose:

  • To evaluate the safety and efficacy of percutaneous myocardial laser revascularization (PMR) in patients with severe angina pectoris due to end-stage coronary artery disease.
  • To assess the impact of PMR on clinical symptoms and exercise capacity.
  • To investigate potential pathophysiological mechanisms underlying PMR's therapeutic effects.

Related Experiment Videos

Summary:

  • PMR was performed in 101 patients with refractory angina. Patients received 1 or 2-3 regions treated in a single session, with 12.3 +/- 4.5 channels created per region.
  • Significant improvements in Canadian Cardiovascular Society (CCS) class (from 3.3 +/- 0.4 to 1.6 +/- 0.8 at 6 months, p < 0.001) and exercise capacity (from 397 +/- 125 s to 540 +/- 190 s at 6 months, p < 0.05) were observed.
  • Sustained benefits were noted at 2 years (CCS class 1.3 +/- 0.7, exercise capacity 500 +/- 193 s), but thallium scintigraphy did not show increased perfusion in treated regions, and channels were often occluded.

Impact:

  • PMR demonstrates potential as a safe and feasible therapeutic option for patients with end-stage CAD and refractory angina pectoris.
  • The procedure leads to significant improvements in patient-reported symptoms and objective measures of exercise tolerance.
  • Further research is needed to elucidate the exact pathophysiological mechanisms, such as myocardial denervation or angiogenesis, responsible for the observed clinical benefits, as direct perfusion enhancement is not evident.